These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36452073)

  • 41. TACE-dependent TGFα shedding drives triple-negative breast cancer cell invasion.
    Giricz O; Calvo V; Peterson EA; Abouzeid CM; Kenny PA
    Int J Cancer; 2013 Dec; 133(11):2587-95. PubMed ID: 23729230
    [TBL] [Abstract][Full Text] [Related]  

  • 42. TNK2 preserves epidermal growth factor receptor expression on the cell surface and enhances migration and invasion of human breast cancer cells.
    Howlin J; Rosenkvist J; Andersson T
    Breast Cancer Res; 2008; 10(2):R36. PubMed ID: 18435854
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.
    De Andrade JP; Park JM; Gu VW; Woodfield GW; Kulak MV; Lorenzen AW; Wu VT; Van Dorin SE; Spanheimer PM; Weigel RJ
    Mol Cancer Ther; 2016 Mar; 15(3):503-11. PubMed ID: 26832794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression.
    Stricker TP; Brown CD; Bandlamudi C; McNerney M; Kittler R; Montoya V; Peterson A; Grossman R; White KP
    PLoS Genet; 2017 Mar; 13(3):e1006589. PubMed ID: 28263985
    [TBL] [Abstract][Full Text] [Related]  

  • 45. iRhom2 in the pathogenesis of oral squamous cell carcinoma.
    Agwae ME; Shaw RJ; Triantafyllou A; Greaney FST; Ben Salah K; Risk JM
    Mol Biol Rep; 2020 May; 47(5):3987-3992. PubMed ID: 32236893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A new class of protein cancer biomarker candidates: differentially expressed splice variants of ERBB2 (HER2/neu) and ERBB1 (EGFR) in breast cancer cell lines.
    Omenn GS; Guan Y; Menon R
    J Proteomics; 2014 Jul; 107():103-12. PubMed ID: 24802673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. iRhom2 regulates CSF1R cell surface expression and non-steady state myelopoiesis in mice.
    Qing X; Rogers L; Mortha A; Lavin Y; Redecha P; Issuree PD; Maretzky T; Merad M; McIlwain D; Mak TW; Overall CM; Blobel CP; Salmon JE
    Eur J Immunol; 2016 Dec; 46(12):2737-2748. PubMed ID: 27601030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pyruvate kinase M2 plays a dual role on regulation of the EGF/EGFR signaling via E-cadherin-dependent manner in gastric cancer cells.
    Wang LY; Liu YP; Chen LG; Chen YL; Tan L; Liu JJ; Jazag A; Ren JL; Guleng B
    PLoS One; 2013; 8(6):e67542. PubMed ID: 23840737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The epidermal growth factor receptor/Erb-B/HER family in normal and malignant breast biology.
    Eccles SA
    Int J Dev Biol; 2011; 55(7-9):685-96. PubMed ID: 22161825
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Opposite regulation by PI3K/Akt and MAPK/ERK pathways of tissue factor expression, cell-associated procoagulant activity and invasiveness in MDA-MB-231 cells.
    Hu C; Huang L; Gest C; Xi X; Janin A; Soria C; Li H; Lu H
    J Hematol Oncol; 2012 Jul; 5():16. PubMed ID: 22534171
    [TBL] [Abstract][Full Text] [Related]  

  • 51. TACE/ADAM-17: a component of the epidermal growth factor receptor axis and a promising therapeutic target in colorectal cancer.
    Merchant NB; Voskresensky I; Rogers CM; Lafleur B; Dempsey PJ; Graves-Deal R; Revetta F; Foutch AC; Rothenberg ML; Washington MK; Coffey RJ
    Clin Cancer Res; 2008 Feb; 14(4):1182-91. PubMed ID: 18281553
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways.
    Kovacevic Z; Menezes SV; Sahni S; Kalinowski DS; Bae DH; Lane DJ; Richardson DR
    J Biol Chem; 2016 Jan; 291(3):1029-52. PubMed ID: 26534963
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression of the epidermal growth factor receptor (EGFR) and the phosphorylated EGFR in invasive breast carcinomas.
    Magkou C; Nakopoulou L; Zoubouli C; Karali K; Theohari I; Bakarakos P; Giannopoulou I
    Breast Cancer Res; 2008; 10(3):R49. PubMed ID: 18522728
    [TBL] [Abstract][Full Text] [Related]  

  • 54. GPCR-induced migration of breast carcinoma cells depends on both EGFR signal transactivation and EGFR-independent pathways.
    Hart S; Fischer OM; Prenzel N; Zwick-Wallasch E; Schneider M; Hennighausen L; Ullrich A
    Biol Chem; 2005 Sep; 386(9):845-55. PubMed ID: 16164409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Dependence receptor UNC5A restricts luminal to basal breast cancer plasticity and metastasis.
    Padua MB; Bhat-Nakshatri P; Anjanappa M; Prasad MS; Hao Y; Rao X; Liu S; Wan J; Liu Y; McElyea K; Jacobsen M; Sandusky G; Althouse S; Perkins S; Nakshatri H
    Breast Cancer Res; 2018 May; 20(1):35. PubMed ID: 29720215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prediction of regulatory targets of alternative isoforms of the epidermal growth factor receptor in a glioblastoma cell line.
    Weinholdt C; Wichmann H; Kotrba J; Ardell DH; Kappler M; Eckert AW; Vordermark D; Grosse I
    BMC Bioinformatics; 2019 Aug; 20(1):434. PubMed ID: 31438847
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clathrin switches transforming growth factor-β role to pro-tumorigenic in liver cancer.
    Caballero-Díaz D; Bertran E; Peñuelas-Haro I; Moreno-Càceres J; Malfettone A; López-Luque J; Addante A; Herrera B; Sánchez A; Alay A; Solé X; Serrano T; Ramos E; Fabregat I
    J Hepatol; 2020 Jan; 72(1):125-134. PubMed ID: 31562907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CNKSR1 serves as a scaffold to activate an EGFR phosphatase via exclusive interaction with RhoB-GTP.
    Nishiyama K; Maekawa M; Nakagita T; Nakayama J; Kiyoi T; Chosei M; Murakami A; Kamei Y; Takeda H; Takada Y; Higashiyama S
    Life Sci Alliance; 2021 Sep; 4(9):. PubMed ID: 34187934
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteolytic cleavage and phosphorylation of a tumor-associated ErbB4 isoform promote ligand-independent survival and cancer cell growth.
    Määttä JA; Sundvall M; Junttila TT; Peri L; Laine VJ; Isola J; Egeblad M; Elenius K
    Mol Biol Cell; 2006 Jan; 17(1):67-79. PubMed ID: 16251361
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An update of the mechanisms of resistance to EGFR-tyrosine kinase inhibitors in breast cancer: Gefitinib (Iressa) -induced changes in the expression and nucleo-cytoplasmic trafficking of HER-ligands (Review).
    Ferrer-Soler L; Vazquez-Martin A; Brunet J; Menendez JA; De Llorens R; Colomer R
    Int J Mol Med; 2007 Jul; 20(1):3-10. PubMed ID: 17549382
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.